Literature DB >> 8144651

Intestinal absorption of peptides by coupling to bile acids.

W Kramer1, G Wess, G Neckermann, G Schubert, J Fink, F Girbig, U Gutjahr, S Kowalewski, K H Baringhaus, G Böger.   

Abstract

Poor intestinal absorption of peptides greatly limits their use as drugs for the treatment of chronic diseases. Since bile acids are efficiently absorbed by an active, Na(+)-dependent transport system in the ileum of mammals, model peptides of different chain length were attached to the 3-position of modified 3 beta-(omega-amino-alkoxy)-7 alpha, 12 alpha-dihydroxy-5 beta-cholan-24-oic acid. These peptide-bile acid conjugates inhibited Na(+)-dependent [3H]taurocholate uptake into brush-border membrane vesicles isolated from rabbit ileum in a concentration-dependent manner. Furthermore, photoaffinity labeling of the bile acid-binding proteins of M(r) 93,000 and 14,000, identified as the protein components of the ileal Na(+)-dependent bile acid transport system in rabbit ileum (Kramer, W., Girbig, F., Gutjahr, U., Kowalewski, S., Jouvenal, K., Müller, G., Tripier, D., and Wess, G. (1993) J. Biol. Chem. 268, 18035-18046) by the photoreactive taurocholate analogue, (3,3-azo-7 alpha, 12 alpha-dihydroxy-5 beta [7 beta, -12 beta-3H]cholan-24-oyl)-2-aminoethanesulfonic acid, was inhibited by the peptide-bile acid conjugates. In contrast, the parent peptides and amino acids neither had a significant effect on [3H]taurocholate uptake by ileal brush-border membrane vesicles nor on photoaffinity labeling of the ileal bile acid-binding membrane proteins. The inhibitory effect of peptide-bile acid conjugates on [3H]taurocholate transport and photoaffinity labeling of the bile acid-binding proteins in rabbit ileal vesicles decreased with increasing chain length of the attached peptide radical. By in vivo ileum perfusion in anesthetized rats an intestinal absorption of the bile acid conjugate S3744 of the fluorescent oxaprolylpeptide 4-nitrobenzo-2-oxa-1,3-diazol-beta-Ala-Phe-5-Opr-Gly (S1037) and secretion of the intact compound into bile could be demonstrated, whereas the parent peptide S1037 or its t-butylester S4404 were not absorbed. The intestinal absorption of S3744 showed a similar temperature dependence as [3H]taurocholate absorption and was inhibited by the presence of taurocholate indicating a carrier-mediated uptake of S3744 via the ileal bile acid transporter. In conclusion, these results indicate that oligopeptides can be made enterally absorable by coupling to modified bile acid molecules making use of the specific intestinal absorption pathway for bile acids. This finding may be of great importance for the design and development of orally active peptide drugs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144651

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Bile acid transporter-mediated oral drug delivery.

Authors:  Feiyang Deng; You Han Bae
Journal:  J Control Release       Date:  2020-07-22       Impact factor: 9.776

2.  Pharmacokinetics of a new, orally available ceftriaxone formulation in physical complexation with a cationic analogue of bile acid in rats.

Authors:  Seulki Lee; Sang Kyoon Kim; Dong Yun Lee; Su Young Chae; Youngro Byun
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

3.  Influence of bile acid derivates on tramadol analgesic effect in mice.

Authors:  V Vasovic; Sasa Vukmirovic; M Pjevic; I Mikov; M Mikov; V Jakovljevic
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2010-09       Impact factor: 2.441

4.  Oral absorption of peptides through the cobalamin (vitamin B12) pathway in the rat intestine.

Authors:  J Alsenz; G J Russell-Jones; S Westwood; B Levet-Trafit; P C de Smidt
Journal:  Pharm Res       Date:  2000-07       Impact factor: 4.200

Review 5.  Carrier-mediated intestinal transport of drugs.

Authors:  A Tsuji; I Tamai
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

6.  Molecular modeling of the intestinal bile acid carrier: a comparative molecular field analysis study.

Authors:  P W Swaan; F C Szoka; S Oie
Journal:  J Comput Aided Mol Des       Date:  1997-11       Impact factor: 3.686

7.  Structural requirements of bile acid transporters: C-3 and C-7 modifications of steroidal hydroxyl groups.

Authors:  Vidula Kolhatkar; James E Polli
Journal:  Eur J Pharm Sci       Date:  2012-03-03       Impact factor: 4.384

8.  A new drug carrier, Nalpha-deoxycholyl-L: -lysyl-methylester, for enhancing insulin absorption in the intestine.

Authors:  S Lee; J Lee; D Y Lee; S K Kim; Y Lee; Y Byun
Journal:  Diabetologia       Date:  2005-03-01       Impact factor: 10.122

Review 9.  The sodium bile salt cotransport family SLC10.

Authors:  Bruno Hagenbuch; Paul Dawson
Journal:  Pflugers Arch       Date:  2003-07-08       Impact factor: 3.657

Review 10.  Exploitation of bile acid transport systems in prodrug design.

Authors:  Elina Sievänen
Journal:  Molecules       Date:  2007-08-16       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.